Ownership as of December 30, 2020. Ten largest shareholders.
Namn
A-aktier
B-aktier
Aktiekapital %
Röster %
ANNWALL & ROTHSCHILD INVESTMENTS AB
377 736
410 478
7,02
28,63
ÖHMAN BANK S.A.
-
1 174 017
10,46
8,03
FJÄRDE AP-FONDEN
-
1 112 919
9,91
7,61
SWEDBANK ROBUR NY TEKNIK BTI
-
579 172
5,16
3,96
AMF AKTIEFOND SMÅBOLAG
-
501 585
4,47
3,43
HANDELSBANKEN SVENSKA, SMABOLAGSFOND
-
450 675
4,01
3,08
TREDJE AP-FONDEN
-
438 565
3,91
3,00
CBNY-NORGES BANK
-
329 620
2,94
2,25
UNIONEN
-
322 196
2,87
2,20
DANGOOR, DAVID
-
278 421
2,48
1,90
Summa 10 största ägare
377 736
5 597 648
53,23
64,09
Övriga aktieägare
-
5 250 800
46,77
35,91
Totalt
377 736
10 848 448
100,00
100,00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.